Literature DB >> 27759801

Unusual motor and non-motor symptoms and signs in the early stage of Parkinson's disease.

Hélio A G Teive1, Délcio C Bertucci2, Renato P Munhoz3.   

Abstract

OBJECTIVE: Patients with Parkinson's disease (PD) may present with unusual motor and non-motor symptoms and signs in the early stage of the disease.
METHODS: Cases were collected over a five-year period at two tertiary movement disorders clinics. All had a diagnosis of PD with unusual presentations defined retrospectively as the presence of complaints not objectively related to any of the classic cardinal signs of parkinsonism or the typical early non-motor features of PD.
RESULTS: A total of 15 early PD patients fulfilled the proposed criteria, presenting with symptoms such as atypical tremors, shoulder pain, signs related to the rigid akinetic syndrome, as well as cases of asthenia, rhinorrhea, parosmia, dysgeusia, nocturnal sialorrhea, and color discrimination disorders.
CONCLUSIONS: Unusual motor and non-motor symptoms and signs in the early stage of PD can be difficult to interpret. Specialists should be aware of these conditions as clues to a potential diagnosis.

Entities:  

Mesh:

Year:  2016        PMID: 27759801     DOI: 10.1590/0004-282X20160126

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

Review 1.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

2.  Use of a Modified STROOP Test to Assess Color Discrimination Deficit in Parkinson's Disease.

Authors:  Rebekah G Langston; Tuhin Virmani
Journal:  Front Neurol       Date:  2018-09-12       Impact factor: 4.003

Review 3.  Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.

Authors:  Ida Manna; Andrea Quattrone; Selene De Benedittis; Enrico Iaccino; Aldo Quattrone
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.